PRECIPIO INC (PRPO) Stock Fundamental Analysis
USA - NASDAQ:PRPO - US74019L6020 - Common Stock
20 USD
-0.65 (-3.15%)
Overall PRPO gets a fundamental rating of 2 out of 10. We evaluated PRPO against 100 industry peers in the Health Care Providers & Services industry. PRPO may be in some trouble as it scores bad on both profitability and health. PRPO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PRPO had negative earnings in the past year.
In the past year PRPO had a positive cash flow from operations.
In the past 5 years PRPO always reported negative net income.
PRPO had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of PRPO (-9.57%) is worse than 76.00% of its industry peers.
With a Return On Equity value of -14.66%, PRPO is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.57% | ||
| ROE | -14.66% | ||
| ROIC | N/A |
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRPO has a better Gross Margin (44.69%) than 73.00% of its industry peers.
In the last couple of years the Gross Margin of PRPO has grown nicely.
PRPO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
2. Health
2.1 Basic Checks
PRPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PRPO has more shares outstanding
The number of shares outstanding for PRPO has been increased compared to 5 years ago.
The debt/assets ratio for PRPO is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -3.96, we must say that PRPO is in the distress zone and has some risk of bankruptcy.
PRPO has a worse Altman-Z score (-3.96) than 88.00% of its industry peers.
PRPO has a debt to FCF ratio of 1.47. This is a very positive value and a sign of high solvency as it would only need 1.47 years to pay back of all of its debts.
PRPO has a better Debt to FCF ratio (1.47) than 88.00% of its industry peers.
PRPO has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
PRPO has a better Debt to Equity ratio (0.05) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.47 | ||
| Altman-Z | -3.96 |
ROIC/WACCN/A
WACC9.21%
2.3 Liquidity
PRPO has a Current Ratio of 0.93. This is a bad value and indicates that PRPO is not financially healthy enough and could expect problems in meeting its short term obligations.
PRPO's Current ratio of 0.93 is on the low side compared to the rest of the industry. PRPO is outperformed by 76.00% of its industry peers.
A Quick Ratio of 0.69 indicates that PRPO may have some problems paying its short term obligations.
PRPO's Quick ratio of 0.69 is on the low side compared to the rest of the industry. PRPO is outperformed by 81.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.83% over the past year.
PRPO shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.03%.
PRPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.72% yearly.
EPS 1Y (TTM)54.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.54%
Revenue 1Y (TTM)27.03%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%27.22%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
PRPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRPO is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 57.35 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
PRPO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PRPO (11/6/2025, 3:13:33 PM)
20
-0.65 (-3.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.75%
Inst Owner Change112.8%
Ins Owners12.81%
Ins Owner Change-0.68%
Market Cap32.40M
Revenue(TTM)21.24M
Net Income(TTM)-1801000
Analysts82.86
Price TargetN/A
Short Float %0.03%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.53 | ||
| P/FCF | 57.35 | ||
| P/OCF | 35.41 | ||
| P/B | 2.64 | ||
| P/tB | 36.24 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.35
FCFY1.74%
OCF(TTM)0.56
OCFY2.82%
SpS13.11
BVpS7.59
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.57% | ||
| ROE | -14.66% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.69% | ||
| FCFM | 2.66% |
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.47 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 25.53% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | -3.96 |
F-Score6
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)15.96%
Cap/Depr(5y)23.27%
Cap/Sales(3y)1.67%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.03%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%27.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y114.03%
OCF growth 3YN/A
OCF growth 5YN/A
PRECIPIO INC / PRPO FAQ
What is the fundamental rating for PRPO stock?
ChartMill assigns a fundamental rating of 2 / 10 to PRPO.
What is the valuation status of PRECIPIO INC (PRPO) stock?
ChartMill assigns a valuation rating of 1 / 10 to PRECIPIO INC (PRPO). This can be considered as Overvalued.
How profitable is PRECIPIO INC (PRPO) stock?
PRECIPIO INC (PRPO) has a profitability rating of 1 / 10.